Apricus Biosciences beats by $0.02, misses on revenue

  • Apricus Biosciences (APRI): Q4 EPS of -$0.04 beats by $0.02.
  • Revenue of $0.4M (-83.3% Y/Y) misses by $1.6M.
  • Press Release

Recommended For You

More Trending News

About SEEL Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SEEL--
Seelos Therapeutics, Inc.